Incyte's Capital Expenditures rose 18430.69% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.4 million, marking a year-over-year decrease of 2357.41%. This contributed to the annual value of $86.3 million for FY2024, which is 16553.9% up from last year.
Per Incyte's latest filing, its Capital Expenditures stood at $14.7 million for Q3 2025, which was up 18430.69% from $19.1 million recorded in Q2 2025.
Incyte's Capital Expenditures' 5-year high stood at $66.3 million during Q2 2021, with a 5-year trough of $2.3 million in Q4 2023.
For the 5-year period, Incyte's Capital Expenditures averaged around $21.8 million, with its median value being $17.0 million (2022).
Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 8934.33% in 2023, then soared by 66682.84% in 2024.
Over the past 5 years, Incyte's Capital Expenditures (Quarter) stood at $34.5 million in 2021, then crashed by 38.27% to $21.3 million in 2022, then crashed by 89.34% to $2.3 million in 2023, then surged by 666.83% to $17.4 million in 2024, then fell by 15.17% to $14.7 million in 2025.
Its Capital Expenditures stands at $14.7 million for Q3 2025, versus $19.1 million for Q2 2025 and $3.2 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value